Results
2532
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,532 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$924.43 | 2.0% | 68.1% | US$827.1b | US$995.42 | PE113.4x | E28.5% | 0.6% | Pharmaceuticals & Biotech | ||
UNH | US$575.19 | -0.5% | 13.8% | US$529.5b | US$623.11 | PE37.7x | E23.4% | 1.5% | Healthcare | ||
JNJ | US$162.78 | -2.6% | 2.4% | US$392.9b | US$171.32 | PE23.9x | E7.2% | 3.0% | Pharmaceuticals & Biotech | ||
ABBV | US$193.51 | 0.03% | 25.7% | US$342.4b | US$196.54 | PE64.5x | E25.3% | 3.2% | Pharmaceuticals & Biotech | ||
MRK | US$114.96 | -2.8% | 9.1% | US$293.1b | US$139.03 | PE21.2x | E14.4% | 2.7% | Pharmaceuticals & Biotech | ||
AZN | UK£115.22 | -3.7% | 3.2% | UK£178.6b | UK£138.09 | PE37.2x | E16.4% | 1.9% | Pharmaceuticals & Biotech | ||
TMO | US$611.88 | 0.2% | 22.0% | US$233.2b | US$647.76 | PE37.6x | E10.6% | 0.3% | Pharmaceuticals & Biotech | ||
ABT | US$113.34 | -4.1% | 17.8% | US$199.8b | US$124.12 | PE35.6x | E11.7% | 1.9% | Healthcare | ||
DHR | US$274.20 | 0.6% | 10.9% | US$197.3b | US$288.05 | PE48.8x | E14.3% | 0.4% | Pharmaceuticals & Biotech | ||
AMGN | US$330.92 | -0.6% | 23.0% | US$180.3b | US$325.55 | PE56.8x | E23.8% | 2.7% | Pharmaceuticals & Biotech | ||
ISRG | US$484.40 | 0.2% | 66.6% | US$173.8b | US$483.95 | PE82.2x | E12.5% | n/a | Healthcare | ||
PFE | US$29.50 | -1.1% | -9.0% | US$166.1b | US$33.66 | PS3x | E32.9% | 5.7% | Pharmaceuticals & Biotech | ||
SYK | US$361.00 | -0.8% | 32.0% | US$139.7b | US$372.59 | PE39.9x | E10.8% | 0.9% | Healthcare | ||
ELV | US$527.35 | -3.0% | 17.7% | US$123.8b | US$603.07 | PE18.3x | E11.6% | 1.2% | Healthcare | ||
BSX | US$83.51 | 1.2% | 58.1% | US$123.7b | US$87.26 | PE67.3x | E20.9% | n/a | Healthcare | ||
VRTX | US$462.99 | -3.8% | 31.6% | US$118.7b | US$509.82 | PS11.6x | E46.4% | n/a | Pharmaceuticals & Biotech | ||
REGN | US$1,045.98 | -8.8% | 25.7% | US$117.9b | US$1,157.07 | PE26.1x | E10.5% | n/a | Pharmaceuticals & Biotech | ||
MDT | US$89.76 | 1.3% | 13.7% | US$115.2b | US$94.62 | PE29.3x | E11.2% | 3.1% | Healthcare | ||
HCA | US$401.80 | 1.1% | 61.7% | US$104.7b | US$396.60 | PE18.1x | E6.3% | 0.7% | Healthcare | ||
GILD | US$83.79 | 0.9% | 10.9% | US$104.6b | US$83.54 | PE99x | E36.0% | 3.7% | Pharmaceuticals & Biotech | ||
BMY | US$50.94 | 2.9% | -13.0% | US$101.4b | US$53.34 | PS2.2x | E49.0% | 4.7% | Pharmaceuticals & Biotech | ||
CI | US$353.17 | -0.9% | 22.4% | US$99.2b | US$398.29 | PE26.6x | E19.4% | 1.6% | Healthcare | ||
CSL | AU$286.71 | -2.9% | 13.8% | AU$139.3b | AU$312.49 | PE36.2x | E13.0% | 1.3% | Pharmaceuticals & Biotech | ||
ZTS | US$193.69 | -1.0% | 9.5% | US$87.7b | US$213.12 | PE37.4x | E10.2% | 0.9% | Pharmaceuticals & Biotech |